Novogene at EACR 2025: Innovative Cancer Science
Date: 16-19 June 2025 Location: Lisbon, Portugal Novogene Stand: 37 Official Event Website: EACR 2025
The EACR 2025 Congress: Innovative Cancer Science is a leading international event dedicated to advancing cancer research. This four-day congress brings together a diverse community of researchers, clinicians, and industry professionals to discuss cutting-edge developments in basic, preclinical, and translational cancer science.
What to Expect at EACR 2025- World-Class Scientific Programme: Renowned experts will present the latest breakthroughs and innovative approaches in cancer research.
- Poster Presentations: A platform for researchers to share their findings and engage in discussions.
- Networking Opportunities: Connect with global leaders, establish collaborations, and exchange ideas in a dynamic environment.
- Industry Exhibition: Explore the latest technologies and solutions from leading companies in the field.
Novogene Europe is proud to participate in EACR 2025, showcasing our advanced genomic services tailored for cancer research. Visit us at stand 37 to learn more about how our next-generation sequencing (NGS) solutions can support your research needs. Our team of experts will be available to discuss:
- Whole Genome Sequencing (WGS) for comprehensive genomic analysis
- Whole Exome Sequencing (WES) for identifying key genetic mutations
- RNA Sequencing for transcriptomic profiling
- Epigenetic and single-cell sequencing solutions
Engage with our team and explore how Novogene’s state-of-the-art sequencing technologies can drive innovation in cancer research. Whether you are looking for cutting-edge genomic services or opportunities for collaboration, we look forward to connecting with you in Lisbon.
For more information about the event, visit the EACR 2025 website.